A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of graves' disease in Japanese

Endocrine Journal

Volumn 52, Issue 4, 2005, Pages 471-477

  Mukai, Tokunori ^a   Hiromatsu, Yuji ^a   Fukutani, Tomoka ^a   Ichimura, Michiko ^a   Kaku, Hiroo ^a   Miyake, Ikuyo ^a   Yamada, Kentaro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD40; Graves' disease; Polymorphism

Indexed keywords

CD40 ANTIGEN; THYROID ANTIBODY;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HEALTH STATUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIGENS, CD40; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 25644432043     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.471     Document Type: Article

References (30)

1. Kamijo K (2003) TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr J 50: 113-116.
2. Weetman AP (2000) Graves' disease. N Engl J Med 26: 1236-1248.
3. Prabhakar BS, Bahn RS, Smith TJ (2003) Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24: 802-835.
4. Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel KW (1983) HLA-DR3 and HLA-DR5 associated thyrotoxicosis - two different types of toxic diffuse goiter. J Clin Endocrinol Metab 56: 781-785.
5. Weetman AP, Zhang L, Webb S, Shine B (1990) Analysis of HLA-DQB and HLA-DPB alleles in GD by oligonucleotide probing of enzymatically amplified DNA. Clin Endocrinol (Oxf) 33: 65-71.
6. Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy MI, Kendall-Taylor P, Pearce SH (1999) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 354: 743-744.
7. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165: 6606-6611.
8. Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J (2003) Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur J Endocrinol 148: 13-18.
9. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K (1998) Interferon-γ gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 8: 1013-1017.
10. Fukutani T, Hiromatsu Y, Kaku H, Miyake I, Mukai T, Imamura Y, Kohno S, Takane N, Shoji S, Otabe S, Yamada K (2004) A polymorphism of interferon gamma gene associated with changes of anti-TSH receptor antibodies induced by anti-thyroid drug treatment for Graves' disease in Japanese. Thyroid 14: 93-97.
11. Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K (2000) A polymorphism of the 5′ flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 52: 759-764.
12. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF (1998) A new Graves' disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease. Am J Hum Genet 63: 1749-1756.
13. Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF (1999) Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84: 4656-4664.
14. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P (1999) Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves' disease. Am J Hum Genet 65: 1462-1465.
15. Tomer Y, Concepcion E, Greenberg DA (2002) A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12: 1129-1135.
16. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ (2003) A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13: 919-925.
17. Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SH (2004) Role of the CD40 locus in Graves' disease. Thyroid 14: 506-509.
18. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC (2004) A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) 61: 269-272.
19. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922.
20. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L (1995) Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 182: 1857-1864.
21. Faure GC, Bensoussan-Lejzerowicz D, Bene MC, Aubert V, Leclere J (1997) Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. Clin Immunol Immunopathol 84: 212-215.
22. Metcalfe RA, McIntosh RS, Marelli-Berg F, Lombardi G, Lechler R, Weetman AP (1998) Detection of CD40 on human thyroid follicular cells: analysis of expression and function. J Clin Endocrinol Metab 83: 1268-1274.
23. Kishimoto K, Dong VM, Issazadeh S, Fedoseyeva EV, Waaga AM, Yamada A, Sho M, Benichou G, Auchincloss H Jr, Grusby MJ, Khoury SJ, Sayegh MH (2000) The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 106: 63-72.
24. Carayanniotis G, Masters SR, Noelle RJ (1997) Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90: 421-426.
25. Werner SC (1977) Modification of the classification of the eye changes of Graves' disease: recommendation of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44: 203-204.
26. Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves' disease associated KOZAK sequence SNP enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 2005 Feb 24; [Epub ahead of print]
27. Sempowski GD, Rozenblit J, Smith TJ, Phipps RP (1998) Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 274 (3 Pt 1): C707-C714.
28. Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK (1999) HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J Clin Endocrinol Metab 84: 3182-3186.
29. Onuma H, Ota M, Sugenoya A, Inoko H (1994) Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. Hum Immunol 39: 195-201.
30. Kretowski A, Wawrusiewicz N, Mironczuk K, Mysliwiec J, Kretowska M, Kinalska I (2003) Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease. J Clin Endocrinol Metab 88: 4945-4949.